导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -16.11% | 229/253 |
| 近一周 | -3.22% | 219/261 |
| 近一月 | -4.71% | 169/261 |
| 近一季 | -5.79% | 124/260 |
| 近半年 | -16.51% | 223/256 |
| 近一年 | -19.35% | 216/248 |
| 近两年 | 5.63% | 211/227 |
| 近三年 | -13.42% | 182/209 |
| 成立以来 | 22.47% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-5.07% 824/1070 |
-5.76% 820/1101 |
- - |
- - |
| 2025 | 13.31% 783/1065 |
4.21% 461/1014 |
-1.45% 810/1038 |
17.66% 675/1050 |
-6.23% 755/1065 |
| 2024 | 0.31% 571/1011 |
-0.69% 351/960 |
-2.79% 493/983 |
11.17% 535/991 |
-6.53% 758/1011 |
| 2023 | -15.77% 556/952 |
4.45% 352/880 |
-8.96% 735/895 |
-4.63% 280/915 |
-7.13% 691/952 |
| 2022 | -19.18% 298/867 |
-20.56% 549/773 |
17.57% 60/806 |
-12.28% 410/845 |
-1.35% 503/867 |
| 2021 | -12.16% 501/740 |
-6.53% 403/580 |
13.18% 283/659 |
-19.06% 644/704 |
2.59% 327/740 |
| 2020 | 74.66% 117/554 |
-2.96% 236/419 |
31.27% 109/466 |
14.62% 149/517 |
19.63% 123/554 |
| 2019 | - - |
- - |
- - |
- - |
1.85% 381/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 汇添富内需增长股票C VS. 东吴新产业精选股票A(580008) |